Nektar Therapeutics

NASDAQ:NKTR

Biotechnology

Healthcare
$32.54 -2.04%

-$1.24 today

Market cap
$933.51M
Beta
1.15
P/E (TTM)
-9.3
EPS (TTM)
-$6.39
52W Low $8.27High $109.00

Volume 0.86M

Average 1.00M

Price history

Nektar Therapeutics SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-46.08%

Period high

$100.35

Period low

$32.54

Latest

$32.54

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 13, 2026Nov 12, 2026
8-KNov 13, 2026Nov 13, 2026
8-KNov 12, 2026Nov 12, 2026
SC 13GNov 10, 2026Nov 10, 2026
S-8Oct 20, 2026Oct 19, 2026
8-KOct 1, 2026Oct 1, 2026
SC 13G/ASep 28, 2026Sep 28, 2026
4Sep 25, 2026Sep 25, 2026
8-KSep 25, 2026Sep 25, 2026
4Sep 25, 2026Sep 25, 2026
4Sep 25, 2026Sep 25, 2026
4Sep 25, 2026Sep 25, 2026
4Sep 25, 2026Sep 25, 2026
8-KSep 8, 2026Sep 8, 2026
4Aug 20, 2026Aug 20, 2026

Competitors

Who does Nektar Therapeutics compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about NKTR's filings, answered from its disclosures.

What is the latest NKTR filing?

The latest filing shown is 10-Q dated Nov 13, 2026.

How many recent filings does NKTR have?

Intrinsic Alpha currently shows 20 recent filings for NKTR.